StockWatch
·
Biotechnology
Board Meeting2 May 2026, 06:21 pm

Advanced Enzyme Board Meeting on May 9, 2026 for FY26 Results

AI Summary

Advanced Enzyme Technologies Ltd has scheduled a Board of Directors meeting on May 9, 2026, to consider and approve the Annual Financial Statements (Standalone & Consolidated) for the fiscal year ended March 31, 2026, including the fourth-quarter results. The board will also consider recommending a final dividend for FY26 and/or declaring an interim dividend for FY27. The trading window remains closed until May 11, 2026.

Key Highlights

  • Board meeting scheduled for May 9, 2026, to approve FY26 financial results.
  • Consideration of final dividend for FY26 and/or interim dividend for FY27.
  • Trading window remains closed until May 11, 2026.
  • Meeting details available on the company and stock exchange websites.